Treatment of insulin resistance and disorders associated...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/575 (2006.01) A61K 45/06 (2006.01) A61P 3/10 (2006.01) C07J 9/00 (2006.01)

Patent

CA 2665380

The present invention provides the use of an LXR antagonist, or a physiologically- acceptable pro-drug therefor, in the manufacture of a medicament for combating insulin resistance or a disorder associated therewith. Further provided is a compound being an ester or carbamate of a hydroxycholesterol, a pharmaceutical composition of such a compound or its use in therapy.

L'invention porte sur l'utilisation d'un antagoniste du LXR, ou sa prodrogue physiologiquement acceptable, pour la fabrication d'un médicament combattant la résistance à insuline ou un trouble associé. L'invention porte également sur un composé constitué d'un ester ou carbamate d'hydroxycholestérol, et sur un préparation pharmaceutique comprenant ledit composé et sur son utilisation à des fins thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of insulin resistance and disorders associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of insulin resistance and disorders associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of insulin resistance and disorders associated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1504490

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.